Comparing Semler Scientific (SMLR) & Its Peers

Semler Scientific (NASDAQ:SMLR) is one of 75 public companies in the “Electromedical equipment” industry, but how does it compare to its peers? We will compare Semler Scientific to similar businesses based on the strength of its analyst recommendations, profitability, valuation, institutional ownership, earnings, risk and dividends.

Profitability

This table compares Semler Scientific and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Semler Scientific	27.44%	30.26%	26.34%
Semler Scientific Competitors	-408.26%	-118.52%	-33.89%

Valuation & Earnings

This table compares Semler Scientific and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Semler Scientific	$56.69 million	$14.32 million	12.52
Semler Scientific Competitors	$1.00 billion	$85.24 million	3.16

Semler Scientific’s peers have higher revenue and earnings than Semler Scientific. Semler Scientific is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Volatility & Risk

Semler Scientific has a beta of 0.67, suggesting that its stock price is 33% less volatile than the S&P 500. Comparatively, Semler Scientific’s peers have a beta of 12.90, suggesting that their average stock price is 1,190% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for Semler Scientific and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semler Scientific	0	1	0	0	2.00
Semler Scientific Competitors	164	685	1885	94	2.68

Semler Scientific currently has a consensus target price of $45.00, suggesting a potential upside of 59.69%. As a group, “Electromedical equipment” companies have a potential upside of 57.31%. Given Semler Scientific’s higher probable upside, equities research analysts plainly believe Semler Scientific is more favorable than its peers.

Institutional and Insider Ownership

93.6% of Semler Scientific shares are owned by institutional investors. Comparatively, 47.3% of shares of all “Electromedical equipment” companies are owned by institutional investors. 13.0% of Semler Scientific shares are owned by company insiders. Comparatively, 10.5% of shares of all “Electromedical equipment” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Semler Scientific beats its peers on 7 of the 13 factors compared.

About Semler Scientific

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups, long-term care, or remote patient monitoring organizations. It offers its products through salespersons and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.